3//SEC Filing
Simcere Zaiming, Inc. 3
Accession 0001213900-25-078673
CIK 0001661059other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 9:32 PM ET
Size
5.7 KB
Accession
0001213900-25-078673
Insider Transaction Report
Form 3
NextCure, Inc.NXTC
Simcere Zaiming, Inc.
10% Owner
Holdings
- 338,636(indirect: See footnotes)
Common Stock
Footnotes (3)
- [F1]These securities are directly held by Simcere Zaiming, Inc. ("Simcere Zaiming" or the "Reporting Person") and may be deemed to be indirectly beneficially owned by the other persons.
- [F2]Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd. ("Jiangsu Zaiming") is the sole shareholder of Simcere Zaiming, Inc. Hainan Simcere Zaiming Pharmaceutical Co., Ltd. ("Hainan Zaiming") is the sole shareholder of Jiangsu Zaiming. Simcere Pharmaceutical Group Limited ("Simcere Group") is the controlling shareholder of Hainan Zaiming through several intermediate companies. Mr. Ren Jinsheng is the chief executive officer and chairman of the board of directors of Simcere Group and a director of Hainan Zaiming. Mr. Tang Renhong is a director of Simcere Group, the chief executive officer and chairman of the board of directors of Hainan Zaiming, a director of Jiangsu Zaiming and the chief executive officer and sole director of Simcere Zaiming. Messrs. Ren Jinsheng and Tang Renhong may be deemed to be the beneficial owners having shared voting power and shared investment power over the securities described in this footnote.
- [F3]The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that the Reporting Person is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Documents
Issuer
NextCure, Inc.
CIK 0001661059
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0002080252
Filing Metadata
- Form type
- 3
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 9:32 PM ET
- Size
- 5.7 KB